We know that you may be experiencing challenges trying to get your Wegovy™ prescription filled. We want to explain the situation and what we are doing to address it. We know you have questions and our goal is to provide the best possible support.
We made Wegovy™ available in the US in mid-June and since that time, the demand for this medicine has significantly exceeded our expectations and unfortunately, our initial product supply was not enough to meet all patient needs. We do have extensive production capacity and have already significantly increased the amount of medicine being manufactured. And although it will take us some time, we are confident in our ability to improve supply and better meet demand in the coming months.
What does this mean for you?
The implications are that you may not be able to start treatment with Wegovy™ as quickly as you may like, which we regret. Currently, you may experience a month-long delay or longer in getting your Wegovy™ prescriptions filled, potentially lasting throughout the remainder of the year. We believe we will stabilize supply in early 2022, if not sooner, depending on demand.
We are also working to ensure that those of you who have already started can continue therapy, which means doing what we can in the short-term to manage the number of people initiating treatment with Wegovy™.
Please see a message from Doug Langa, executive vice president,
North America operations and president of Novo Nordisk Inc:
“Many of you took an important step to talk to a healthcare provider about managing your weight, and we fully understand your disappointment with these delays in getting started on Wegovy™. We are sorry that we are not meeting your needs as we would have liked. Please know that we take our responsibility to support you in this journey very seriously and are addressing this issue as a top priority. We are taking every necessary step to meet current and future needs. Thank you for your patience as we work to resolve this issue – which we will, as we know this medicine has the potential to make a meaningful difference for many people for years to come.”
Wegovy™ is a prescription medicine indicated for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems to help them lose weight and keep it off used with a reduced-calorie meal plan and increased physical activity.
Please see below for important information, and don’t hesitate to call 1-833-4-WEGOVY (1-833-493-4689) and select option 0 for more support. You are our number one priority and we’re here to help.
If you have additional comments or would like to provide feedback on what other information would be helpful to you, please contact our Customer Care Center at 1-800-727-6500 or submit online. We will be reviewing that information on an ongoing basis and making periodic updates to this page. Please know that we take our responsibility to support you in this journey very seriously and are addressing this issue as a top priority. Thank you for your patience as we work to resolve this issue – which we will.
Your Career Guide